Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Morristown Medical Center located at 100 Madison Ave, Morristown, NJ, 07960 & includes data from NPIs 1700822806, 1891731998, 1881947000, 1518903616, 1053384776
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark mortality rates for Morristown Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,690 | 3,547 | ||||||||||||||||||||||
| Surgical | 1,554 | 1,520 | ||||||||||||||||||||||
| Non Surgical | 2,136 | 2,027 | ||||||||||||||||||||||
| Cardiovascular | 961 | 930 | ||||||||||||||||||||||
| Orthopedics | 657 | 652 | ||||||||||||||||||||||
| General Medicine | 496 | 454 | ||||||||||||||||||||||
| General Surgery | 320 | 302 | ||||||||||||||||||||||
| Gastroenterology & Endocrinology | 281 | 267 | ||||||||||||||||||||||
| Neurology | 222 | 208 | ||||||||||||||||||||||
| Urology | 212 | 210 | ||||||||||||||||||||||
| Pulmonology | 199 | 188 | ||||||||||||||||||||||
| Oncology & Hematology | 109 | 108 | ||||||||||||||||||||||
| Spine | 75 | 74 | ||||||||||||||||||||||
| Psychiatry & Mental Disorders | 68 | 66 | ||||||||||||||||||||||
| Colorectal | 43 | 41 | ||||||||||||||||||||||
| Obstetrics & Gynecology | 31 | 31 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Coronary Bypass | ||||||||||||||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 233: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Endovascular Procedures | ||||||||||||||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||||||||||||||
| DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Acute Myocardial Infarction | ||||||||||||||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
| DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 244: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Vascular Procedures | ||||||||||||||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||||||||||||||
| DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Aortic And Heart Assist Procedures | ||||||||||||||||||||||||
| DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Syncope And Collapse | ||||||||||||||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
| Peripheral Vascular Disorders | ||||||||||||||||||||||||
| Atherosclerosis | ||||||||||||||||||||||||
| DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Cardiothoracic Procedures | ||||||||||||||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||||||||||||||
| Hypertension |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Medical Back Problems | ||||||||||||||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Bilateral Or Multiple Major Joint Procedures Of Lower Extremity | ||||||||||||||||||||||||
| DRG 462: BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
| Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||||||||||||||
| DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||||||||||||||
| Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||||||||||||||
| DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cellulitis | ||||||||||||||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Aftercare | ||||||||||||||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Postoperative And Post-Traumatic Infections | ||||||||||||||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
| Signs And Symptoms |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Chest Procedures | ||||||||||||||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Extracranial Procedures | ||||||||||||||||||||||||
| DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||||||||||||||
| DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Peritoneal Adhesiolysis | ||||||||||||||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||||||||||||||
| Other Digestive System O.R. Procedures | ||||||||||||||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Digestive System Diagnoses | ||||||||||||||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| G.I. Obstruction | ||||||||||||||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Diabetes | ||||||||||||||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||||||||||||||
| Disorders Of Biliary Tract | ||||||||||||||||||||||||
| Cholecystectomy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||||||||||||||
| Transient Ischemia | ||||||||||||||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||||||||||||||
| Seizures | ||||||||||||||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Renal Failure | ||||||||||||||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pulmonary Embolism | ||||||||||||||||||||||||
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pneumothorax | ||||||||||||||||||||||||
| Respiratory System Diagnosis With Ventilator Support |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Digestive Malignancy | ||||||||||||||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New Jersey Total Hospitalizations (Jul 2017 to Sep 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey In Hospital Mortality Rate (%) | New Jersey 30 Day Mortality Rate (%) | New Jersey 60 Day Mortality Rate (%) | New Jersey 90 Day Mortality Rate (%) | New Jersey 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy |